Key clinical message:
Chromoblastomycosis, though rare in non-endemic regions like Lebanon,
should be considered in patients presenting with chronic, verrucous skin
lesions unresponsive to conventional therapies. Multimodal treatment
combining oral antifungals, cryotherapy, and adjunctive topical
therapies like 5-Fluorouracil demonstrates efficacy in managing
refractory cases.